Mayers Douglas L

Avg. Two Year Performance

(44%) Avg. Purchase Return
(20%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return35%41%95%(40%)(44%)
Purchase Success Rate1 of 11 of 11 of 10 of 10 of 1
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

EVP and Chief Medical Officer:

Holdings: 30.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Related Products

CHIEF MEDICAL OFFICER:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--